市場調査レポート

商品コード

1576095

放射線治療機器市場：製品別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Radiotherapy Devices Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年10月24日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 231 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 679,320円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 860,472円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,237,872円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.96円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の放射線治療機器の市場規模は、予測期間の2024年～2031年に5.90%のCAGRで拡大し、2023年の64億3,000万米ドルから2031年には101億7,000万米ドルに成長すると予測されています。放射線治療機器は、がん患者に効果的な治療と症状の緩和を提供します。世界中でがん患者が増加していること、患者やヘルスケア検索プロバイダーの間で新規かつ有望な治療法に対する認識が高まっていること、放射線治療によって有望な結果がもたらされることが、放射線治療機器の需要を促進する主な要因となっています。さらに、開発された技術の導入とこの分野における継続的な開発が成長を支えています。政府の支援や投資も放射線治療機器の使用を後押ししています。これらは、放射線治療技術を腫瘍治療に開発・採用するための基盤となっており、がん患者が世界中で利用できる治療選択肢を変革しています。

主要な放射線治療機器市場が行う研究開発への投資の増加は、新しく改良された技術や治療法の開発につながっています。このような参入企業が製品を増やし、世界のプレゼンスを高めると競合が増え、市場の進化をさらに後押しすることになります。このような成長は、より多くの投資を呼び込み、市場の勢いを強めます。

さらに、医療施設への放射線治療機器の設置が進むことで、治療の精度とペースが向上すると予想されています。患者の治療に採用されるこれらの新技術は、患者にとってより良い解決策を模索しています。このような新技術の導入が放射線治療機器市場の成長を支えています。

当レポートでは、世界の放射線治療機器市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

市場リーダートップ5の競合マトリックス
参入企業トップ5のSWOT分析
市場参入企業トップ10の情勢
- Varian Medical Systems, Inc.
- BEBIG Medical GmbH
- Toshiba Energy Systems & Solutions Corporation
- Koninklijke Philips N.V.
- Mitsubishi Electric Corporation
- AngioDynamics, Inc.
- Accuray Incorporated
- IBA Dosimetry GmbH
- Elekta AB
- Brainlab AG

第22章戦略的提言

第23章お問い合わせと免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 2. Global Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 3. Global Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 4. Global Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 5. Global Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 6. Global Radiotherapy Devices Market Share (%), By Region, 2017-2031F
Figure 7. North America Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 8. North America Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 9. North America Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 10. North America Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 11. North America Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 12. North America Radiotherapy Devices Market Share (%), By Country, 2017-2031F
Figure 13. United States Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 14. United States Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 15. United States Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 16. United States Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 17. United States Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 19. Canada Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 20. Canada Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 21. Canada Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 22. Canada Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 24. Mexico Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 25. Mexico Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 26. Mexico Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 29. Europe Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 30. Europe Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 31. Europe Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 32. Europe Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Radiotherapy Devices Market Share (%), By Country, 2017-2031F
Figure 34. Germany Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 35. Germany Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 36. Germany Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 37. Germany Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 38. Germany Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 39. France Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 40. France Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 41. France Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 42. France Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 43. France Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 45. Italy Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 46. Italy Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 47. Italy Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 48. Italy Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 50. United Kingdom Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 51. United Kingdom Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 52. United Kingdom Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 55. Russia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 56. Russia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 57. Russia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 58. Russia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 60. Netherlands Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 61. Netherlands Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 62. Netherlands Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 65. Spain Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 66. Spain Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 67. Spain Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 68. Spain Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 70. Turkey Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 71. Turkey Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 72. Turkey Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 75. Poland Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 76. Poland Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 77. Poland Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 78. Poland Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 79. South America Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 80. South America Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 81. South America Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 82. South America Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 83. South America Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 84. South America Radiotherapy Devices Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 86. Brazil Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 87. Brazil Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 88. Brazil Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 91. Argentina Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 92. Argentina Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 93. Argentina Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 96. Asia-Pacific Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 97. Asia-Pacific Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 98. Asia-Pacific Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Radiotherapy Devices Market Share (%), By Country, 2017-2031F
Figure 101. India Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 102. India Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 103. India Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 104. India Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 105. India Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 106. China Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 107. China Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 108. China Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 109. China Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 110. China Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 112. Japan Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 113. Japan Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 114. Japan Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 115. Japan Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 117. Australia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 118. Australia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 119. Australia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 120. Australia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 122. Vietnam Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 123. Vietnam Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 124. Vietnam Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 127. South Korea Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 128. South Korea Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 129. South Korea Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 132. Indonesia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 133. Indonesia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 134. Indonesia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 137. Philippines Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 138. Philippines Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 139. Philippines Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 142. Middle East & Africa Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 143. Middle East & Africa Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 144. Middle East & Africa Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Radiotherapy Devices Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 148. Saudi Arabia Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 149. Saudi Arabia Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 150. Saudi Arabia Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 153. UAE Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 154. UAE Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 155. UAE Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 156. UAE Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Radiotherapy Devices Market, By Value, in USD Billion, 2017-2031F
Figure 158. South Africa Radiotherapy Devices Market, By Volume, in Million Units, 2017-2031F
Figure 159. South Africa Radiotherapy Devices Market Share (%), By Product, 2017-2031F
Figure 160. South Africa Radiotherapy Devices Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Radiotherapy Devices Market Share (%), By End-user, 2017-2031F
Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX12142

Global radiotherapy devices market is projected to witness a CAGR of 5.90% during the forecast period 2024-2031, growing from USD 6.43 billion in 2023 to USD 10.17 billion in 2031. Radiotherapy devices offer effective treatment and symptom relief to cancer patients. Rising cancer cases across the globe, growing awareness about novel and promising treatments among patients and healthcare search providers, and promising outcomes delivered by radiotherapy are the key factors driving the demand for radiotherapy devices. Further, the incorporation of developed technologies and continuous developments in the area supports the growth. Government support and investments serve to boost the use of radiotherapy devices. Altogether, they form the base for the developing and adopting radiotherapy technologies in oncological treatment, thus transforming therapeutic options available worldwide for cancer patients.

Increased investments in research and development conducted by the major radiotherapy devices market led to the development of new, improved technologies and treatment alternatives. When these players increase their products and global presence, competition rises, which further propelling the market's evolution. It is such growth that draws in more investment and strengthens the momentum in the market. For instance, in October 2023, Elekta AB completed the acquisition of iCAD, Inc., which comprised the Xoft Axxent Electronic Brachytherapy System. This strategic decision empowers Elekta AB to provide enhanced electronic brachytherapy alternatives, indicating the increasing need for various cancer treatment modalities.

Furthermore, the growing installation of radiotherapy devices in medical facilities is anticipated to improve the accuracy and pace of the treatment. These new technologies adopted for treating patients look for solutions that could be better for the patient. This introduction of new technologies supports the growth of the radiotherapy devices market. For instance, in December 2022, IBA Dosimetry GmbH signed an agreement with the Ministry of Health of Spain to install ten proton therapy systems as a part of a public tender. Such a contract shows the growing importance of innovative technologies in oncology treatments.

Expanding Role of Radiotherapy Devices to Drive Market Demand

The growing incidence of cancer and the increasing demand for advanced cancer treatment are influencing the market's growth for radiotherapy devices. Increasingly, there is a rising demand for effective therapies for various malignant tumors, such as breast, lung, prostate, and colorectal. According to the World Health Organization, there were an estimated 20 million new cancer cases in 2022, and these cases are anticipated to rise. The increasing trend in cases projects a rise in patients requiring radiation therapies and sophisticated treatment methods for cancer management. In response to the growing cancer burden, governments are implementing strategies and taking initiatives to develop cancer care and encourage people to avail effective treatment options. As such, it would increase the focus on radiotherapy devices and propel growth and innovation in the cancer treatment solutions market in the forecast period. For instance, in October 2023, Elekta AB won a public tender from Ukraine's Ministry of Health to deliver Harmony linear accelerators for cancer treatment. Under this partnership, Ukrainian patients will gain access to high-end radiation therapy equipment, thus improving treatment options and driving the market forward.

Technological Advancements to Drive the Radiotherapy Device Market Growth

The radiotherapy market is expanding rapidly due to the advancements in radiological equipment, especially with the incorporation of artificial intelligence. For instance, AI algorithms in AI-powered radiotherapy devices can swiftly evaluate the new imaging data, allowing instant adjustments to the treatment regimens before or during sessions. Also, technological developments in MRI and CT scanners improve the accuracy of tumor detection during treatment. Additionally, adaptive radiotherapy systems can modify the treatment plans in response to tumor size or anatomical alterations to ensure the patient receives the optimal radiation dosage during treatment. Such technologies contribute to increased treatment efficiency for cancer patients undergoing radiotherapy, resulting in better outcomes than traditional forms of care. For instance, in September 2024, Elekta AB obtained CE marking in Europe for its AI-powered adaptive CT-linear accelerator called the Elekta Evo. It allows clinicians to choose online or offline treatment adaptation options by selecting the radiation therapy that best suits an individual cancer patient.

Increasing Government Fundings to Fuel Market Growth

Increasing government funding and initiatives are the key drivers for the radiotherapy devices market. As the global incidence rate of cancer continues to grow, governments are investing in the healthcare system to improve treatment and access to cancer care. Funds are allocated to advanced radiotherapy technologies to gradually introduce sophisticated equipment for better treatment efficacy in medical facilities. The governments allocate funding to hospitals and clinics to adopt cutting-edge technologies, improving patient outcomes and treatment services. For instance, in January 2023, The Health Minister of Wales allocated USD 116.1 million (GBP 86 million) to strengthen radiotherapy services for cancer in South Wales, United States. Funding is part of a long-term initiative to deliver cancer care in southeast Wales, with assured equipment, advanced techniques, and two additional machines to deal with rising demands for treatment. Public health campaigns, such as promotions, to increase awareness regarding cancer prevention and early presentation trigger demand for radiotherapy service delivery. Strategic partnerships between government entities and healthcare institutions encourage collaboration in improving cancer care. Government support, in turn, contributes very much to responsive and robust radiotherapy devices market benefits for both patients and the health system.

Hospitals to Dominate the Global Radiotherapy Devices Market Share

Among end-users, hospitals dominate the share of the global radiotherapy devices market. Cancer treatment has become a key focus for healthcare facilities, leading hospitals to buy more radiotherapy devices to boost patient care. The rising number of cancer cases and the need for good treatment options fuel the market trend. Hospitals invest in cutting-edge tech, such as linear accelerators and imaging systems, to give exact and quick radiation therapy. The focus on better treatment results and patient safety speeds up this uptake. Also, hospitals now use adaptive radiotherapy systems, which allow changes to treatment plans in real time to give each patient tailored care. The high demand from hospitals plays an important role in the growth of the radiotherapy devices market. For instance, in June 2024, Heidelberg University Hospital in Germany installed its new Radixact System to advance its cancer care approach. The system features ClearRT imaging, Synchrony motion tracking, and a VOLO Ultra Optimizer that delivers improved workflow, image clarity, and precision to help the hospital by serving patients more effectively.

North America to Dominate the Global Radiotherapy Device Market Share

North America is anticipated to lead the share of the radiotherapy devices market. The presence of several major players in the region is one of the critical factors. Advanced technology and robust infrastructures in healthcare intensify the growth of the market. Integration of telemedicine in radiotherapy has transformed patient care through improvement in accessibility and the adoption of a more patient-centered approach. The growing installation and deployment of radiotherapy devices in hospitals propel market growth. For instance, in June 2023, Northwell Lenox Hill Hospital became the first in New York State to implement the HyperSight imaging solution offered by Varian Medical Systems, Inc., leveraging advanced cone-beam computed tomography on its Halcyon linear accelerator for high-precision radiation therapy. This introduction aids clinicians in quickly gathering information and images during the treatment, improving the patient's experience. Also, evolving reimbursement models incentivize healthcare facilities to invest in modern radiotherapy technologies, aligning financial benefits with quality care. The growing number of radiation oncology centers is enhancing access, particularly in rural communities, and addressing treatment accessibility issues. In addition, advanced analytics and machine learning completely transform treatment planning and monitoring, ensuring more accurate and individualized approaches to therapy, which are critical in enhancing patient outcomes in cancer treatment.

Future Market Scenario (2024 - 2031F)

Advancements in radiotherapy technology hold great promise for the market. The integration of AI technology creates the opportunity to produce personalized treatment planning. Improved imaging techniques to visualize tumors better and stereotactic body radiation therapy (SBRT) development to achieve highly targeted treatment applications. Other trends include proton therapy and adaptive radiotherapy, which can adapt to real-time changes. The demand for outpatient care and combination therapies will increase in the forecast period, pushing the market for portable and user-friendly devices so that radiotherapy can reach more patients efficiently around the world. For instance, in November 2023, Henry Ford West Bloomfield Hospital introduced AI-enhanced radiation therapy for cancer treatment. This new generation improves precision and comfort and reduces side effects. Radiation oncologists can easily personalize treatments with the Ethos system and HyperSight for optimal radiation delivery to tumors and simplify the adaptive radiotherapy process for efficiency and patient care.

Key Players Landscape and Outlook

Innovation continues to shape the market for radiotherapy devices, and major players are concentrating on improvements to ensure consistency and accuracy in treatment. Companies look toward more advanced technologies such as AI integration, adaptive treatment planning, and higher-resolution imaging. With the increase in demand for more precise and efficient cancer treatments, collaborations, new launches, and innovative development will increase the competition in the market. Supply chain resilience and sustainable practices will drive the changed landscape of the dynamic market.

In August 2024, Elekta AB partnered with Liaoning Huaxing AnSheng Software Technology Co., Ltd. (AnSheng). This collaboration would enhance the market position of Elekta AB in China. Elekta AB is investing in AnSheng to improve its products and customer experience, giving precedence to vendor-neutral oncology information systems tailored for China and, in the future, improving quality and efficiency in cancer care. Moreover, in August 2023, BEBIG Medical GmbH signed an agreement with Shinva Medical Instrument Co., Ltd. to develop a long-term cooperation based on the global linear accelerator (LINAC) market. Such collaboration combines the strengths of companies in dependable hardware and easy-to-handle operating systems. In that way, LINAC technology has the potential to reach a broader population and be used more frequently.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Voice of Customer

4.1. Product and Market Intelligence
4.2. Mode of Brand Awareness
4.3. Factors Considered in Purchase Decisions
- 4.3.1. Features and Other Value-added Service
- 4.3.2. Infrastructure Compatibility
- 4.3.3. Efficiency of Solutions
- 4.3.4. After-Sales Support
4.4. Consideration of Privacy and Regulations

5. Global Radiotherapy Devices Market Outlook, 2017-2031F

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share Analysis & Forecast
- 5.2.1. By Product
  - 5.2.1.1. External Beam Radiation Therapy Devices
    - 5.2.1.1.1. Advanced Linear Accelerators
      - 5.2.1.1.1.1. Gamma Knife
      - 5.2.1.1.1.2. Cyberknife
      - 5.2.1.1.1.3. TomoTherapy
      - 5.2.1.1.1.4. MRI LINAC
    - 5.2.1.1.2. Conventional Linear Accelerators
    - 5.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
    - 5.2.1.1.4. Proton Therapy Devices
      - 5.2.1.1.4.1. Cyclotrons
      - 5.2.1.1.4.2. Synchrotron
      - 5.2.1.1.4.3. Synchrocyclotron
  - 5.2.1.2. Internal Beam Radiation Therapy Devices
    - 5.2.1.2.1. Brachytherapy Devices
    - 5.2.1.2.2. Consumables
  - 5.2.1.3. Others
- 5.2.2. By Application
  - 5.2.2.1. Lung Cancer
  - 5.2.2.2. Breast Cancer
  - 5.2.2.3. Prostate Cancer
  - 5.2.2.4. Head and Neck Cancer
  - 5.2.2.5. Other Applications
- 5.2.3. By End-user
  - 5.2.3.1. Hospitals
  - 5.2.3.2. Ambulatory Surgical Centers
  - 5.2.3.3. Cancer Care Centers
- 5.2.4. By Region
  - 5.2.4.1. North America
  - 5.2.4.2. Europe
  - 5.2.4.3. Asia-Pacific
  - 5.2.4.4. South America
  - 5.2.4.5. Middle East and Africa
- 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
5.3. Market Map Analysis, 2023
- 5.3.1. By Product
- 5.3.2. By Application
- 5.3.3. By End-user
- 5.3.4. By Region

6. North America Radiotherapy Devices Market Outlook, 2017-2031F*

6.1. Market Size Analysis & Forecast
- 6.1.1. By Value
- 6.1.2. By Volume
6.2. Market Share Analysis & Forecast
- 6.2.1. Product
  - 6.2.1.1. External Beam Radiation Therapy Devices
    - 6.2.1.1.1. Advanced Linear Accelerators
      - 6.2.1.1.1.1. Gamma Knife
      - 6.2.1.1.1.2. Cyberknife
      - 6.2.1.1.1.3. TomoTherapy
      - 6.2.1.1.1.4. MRI LINAC
    - 6.2.1.1.2. Conventional Linear Accelerators
    - 6.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
    - 6.2.1.1.4. Proton Therapy Devices
      - 6.2.1.1.4.1. Cyclotrons
      - 6.2.1.1.4.2. Synchrotron
      - 6.2.1.1.4.3. Synchrocyclotron
  - 6.2.1.2. Internal Beam Radiation Therapy Devices
    - 6.2.1.2.1. Brachytherapy Devices
    - 6.2.1.2.2. Consumables
  - 6.2.1.3. Others
- 6.2.2. By Application
  - 6.2.2.1. Lung Cancer
  - 6.2.2.2. Breast Cancer
  - 6.2.2.3. Prostate Cancer
  - 6.2.2.4. Head and Neck Cancer
  - 6.2.2.5. Other Applications
- 6.2.3. By End-user
  - 6.2.3.1. Hospitals
  - 6.2.3.2. Ambulatory Surgical Centers
  - 6.2.3.3. Cancer Care Centers
- 6.2.4. By Country Share
  - 6.2.4.1. United States
  - 6.2.4.2. Canada
  - 6.2.4.3. Mexico
6.3. Country Market Assessment
- 6.3.1. United States Radiotherapy Devices Market Outlook, 2017-2031F*
  - 6.3.1.1. Market Size Analysis & Forecast
    - 6.3.1.1.1. By Value
    - 6.3.1.1.2. By Volume
  - 6.3.1.2. Market Share Analysis & Forecast
    - 6.3.1.2.1. Product
      - 6.3.1.2.1.1. External Beam Radiation Therapy Devices
      - 6.3.1.2.1.1.1. Advanced Linear Accelerators
      - 6.3.1.2.1.1.1.1. Gamma Knife
      - 6.3.1.2.1.1.1.2. Cyberknife
      - 6.3.1.2.1.1.1.3. TomoTherapy
      - 6.3.1.2.1.1.1.4. MRI LINAC
      - 6.3.1.2.1.1.2. Conventional Linear Accelerators
      - 6.3.1.2.1.1.3. Conventional Cobalt-60 Teletherapy Units
      - 6.3.1.2.1.1.4. Proton Therapy Devices
      - 6.3.1.2.1.1.4.1. Cyclotrons
      - 6.3.1.2.1.1.4.2. Synchrotron
      - 6.3.1.2.1.1.4.3. Synchrocyclotron
      - 6.3.1.2.1.2. Internal Beam Radiation Therapy Devices
      - 6.3.1.2.1.2.1. Brachytherapy Devices
      - 6.3.1.2.1.2.2. Consumables
      - 6.3.1.2.1.3. Others
    - 6.3.1.2.2. By Application
      - 6.3.1.2.2.1. Lung Cancer
      - 6.3.1.2.2.2. Breast Cancer
      - 6.3.1.2.2.3. Prostate Cancer
      - 6.3.1.2.2.4. Head and Neck Cancer
      - 6.3.1.2.2.5. Other Applications
    - 6.3.1.2.3. By End-user
      - 6.3.1.2.3.1. Hospitals
      - 6.3.1.2.3.2. Ambulatory Surgical Centers
      - 6.3.1.2.3.3. Cancer Care Centers
- 6.3.2. Canada
- 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Radiotherapy Devices Market Outlook, 2017-2031F

7.1. Germany
7.2. France
7.3. Italy
7.4. United Kingdom
7.5. Russia
7.6. Netherlands
7.7. Spain
7.8. Turkey
7.9. Poland

8. Asia-Pacific Radiotherapy Devices Market Outlook, 2017-2031F

8.1. India
8.2. China
8.3. Japan
8.4. Australia
8.5. Vietnam
8.6. South Korea
8.7. Indonesia
8.8. Philippines

9. South America Radiotherapy Devices Market Outlook, 2017-2031F

9.1. Brazil
9.2. Argentina

10. Middle East and Africa Radiotherapy Devices Market Outlook, 2017-2031F

10.1. Saudi Arabia
10.2. UAE
10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

17.1. Market Drivers
17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework and Innovation

19.1. Regulatory Approvals

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Varian Medical Systems, Inc.
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 21.3.2. BEBIG Medical GmbH
- 21.3.3. Toshiba Energy Systems & Solutions Corporation
- 21.3.4. Koninklijke Philips N.V.
- 21.3.5. Mitsubishi Electric Corporation
- 21.3.6. AngioDynamics, Inc.
- 21.3.7. Accuray Incorporated
- 21.3.8. IBA Dosimetry GmbH
- 21.3.9. Elekta AB
- 21.3.10. Brainlab AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

放射線治療機器市場：製品別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Radiotherapy Devices Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の放射線治療機器市場の見通し、2017年～2031年

第6章 北米の放射線治療機器市場の見通し、2017年～2031年

第7章 欧州の放射線治療機器市場の見通し、2017年～2031年

第8章 アジア太平洋の放射線治療機器市場の見通し、2017年～2031年

第9章 南米の放射線治療機器市場の見通し、2017年～2031年

第10章 中東・アフリカの放射線治療機器市場の見通し、2017年～2031年

第11章 需要供給分析

第12章 輸出入の分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 価格分析

第17章 市場力学

第18章 市場の動向と発展

第19章 規制枠組みとイノベーション

第20章 ケーススタディ

第21章 競合情勢

第22章 戦略的提言

第23章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Radiotherapy Devices Market Outlook, 2017-2031F

6. North America Radiotherapy Devices Market Outlook, 2017-2031F*

7. Europe Radiotherapy Devices Market Outlook, 2017-2031F

8. Asia-Pacific Radiotherapy Devices Market Outlook, 2017-2031F

9. South America Radiotherapy Devices Market Outlook, 2017-2031F

10. Middle East and Africa Radiotherapy Devices Market Outlook, 2017-2031F

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

18. Market Trends and Developments

19. Regulatory Framework and Innovation

20. Case Studies

21. Competitive Landscape

22. Strategic Recommendations

23. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章顧客の声

第5章世界の放射線治療機器市場の見通し、2017年～2031年

第6章北米の放射線治療機器市場の見通し、2017年～2031年

第7章欧州の放射線治療機器市場の見通し、2017年～2031年

第8章アジア太平洋の放射線治療機器市場の見通し、2017年～2031年

第9章南米の放射線治療機器市場の見通し、2017年～2031年

第10章中東・アフリカの放射線治療機器市場の見通し、2017年～2031年

第11章需要供給分析

第12章輸出入の分析

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第16章価格分析

第17章市場力学

第18章市場の動向と発展

第19章規制枠組みとイノベーション

第20章ケーススタディ

第21章競合情勢

第22章戦略的提言

第23章お問い合わせと免責事項